JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M311602200 on December 2, 2003

J. Biol. Chem., Vol. 279, Issue 8, 7346-7352, February 20, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/8/7346    most recent
M311602200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, V. K.
Right arrow Articles by Pillinger, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, V. K.
Right arrow Articles by Pillinger, M. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Carboxyl Methylation of Ras Regulates Membrane Targeting and Effector Engagement*

Vi K. Chiu{ddagger}§, Joseph Silletti{ddagger}§, Victoria Dinsell{ddagger}, Heidi Wiener{ddagger}§, Kristina Loukeris{ddagger}, Guoming Ou{ddagger}, Mark R. Philips{ddagger}§||, and Michael H. Pillinger{ddagger}¶||**{ddagger}{ddagger}

From the Departments of {ddagger}Medicine, §Cell Biology, and ||Pharmacology, New York University School of Medicine, New York, New York 10016, The Hospital for Joint Diseases, New York, New York 10003, and **the Department of Medicine of the New York Harbor Healthcare System of Veterans Affairs, New York, New York 10010

Post-translational modification of Ras proteins includes prenylcysteine-directed carboxyl methylation. Because Ras participates in Erk activation by epidermal growth factor (EGF), we tested whether Ras methylation regulates Erk activation. EGF stimulation of Erk was inhibited by AFC (N-acetyl-S-farnesyl-L-cysteine), an inhibitor of methylation, but not AGC (N-acetyl-S-geranyl-L-cysteine), an inactive analog of AFC. AFC inhibited Ras methylation as well as the activation of pathway enzymes between Ras and Erk but did not inhibit EGF receptor phosphorylation, confirming action at the level of Ras. Transient transfection of human prenylcysteine-directed carboxyl methyltransferase increased EGF-stimulated Erk activation. AFC but not AGC inhibited movement of transiently transfected green fluorescent protein-Ras from the cytosol to the plasma membrane of COS-1 cells and depleted green fluorescent protein-Ras from the plasma membrane in stably transfected Madin-Darby canine kidney cells, suggesting that methylation regulates Erk by ensuring proper membrane localization of Ras. However, when COS-1 cells were transfected with Ras complexed to CD8, plasma membrane localization of Ras was unaffected by AFC, yet EGF-stimulated Erk activation was inhibited by AFC. Thus, Ras methylation appears to regulate Erk activation both through the localization of Ras as well as the propagation of Ras-dependent signals.


Received for publication, October 22, 2003 , and in revised form, December 1, 2003.

* This work was supported by Arthritis Foundation, New York Chapter, Young Scholar and Research Grants (to M. H. P.), by National Institutes of Health Grants AI36224 and GM55279 (to M. R. P.), the Burroughs Wellcome Foundation (to M. R. P), and National Institutes of Health General Clinical Research Center Grant NCRR M01RR00096. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed: Div. of Rheumatology, Dept. of Medicine 630-111J, New York Harbor Healthcare System, 423 E. 23rd St., New York, NY 10010. Tel.: 212-951-3328; Fax: 212-951-3329; E-mail: michael.pillinger{at}med.nyu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
Y. Chen, K. J. McQuade, X.-J. Guan, P. A. Thomason, M. S. Wert, J. B. Stock, and E. C. Cox
Isoprenylcysteine Carboxy Methylation Is Essential for Development in Dictyostelium discoideum
Mol. Biol. Cell, October 1, 2007; 18(10): 4106 - 4118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. F. Leung, R. Baron, B. R. Ali, A. I. Magee, and M. C. Seabra
Rab GTPases Containing a CAAX Motif Are Processed Post-geranylgeranylation by Proteolysis and Methylation
J. Biol. Chem., January 12, 2007; 282(2): 1487 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Anderson, B. S. Henriksen, R. A. Gibbs, and C. A. Hrycyna
The Isoprenoid Substrate Specificity of Isoprenylcysteine Carboxylmethyltransferase: DEVELOPMENT OF NOVEL INHIBITORS
J. Biol. Chem., August 19, 2005; 280(33): 29454 - 29461.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. R. Philips
Methotrexate and Ras Methylation: A New Trick for an Old Drug?
Sci. Signal., March 23, 2004; 2004(225): pe13 - pe13.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.